Acadia pharmaceuticals reports inducement grants under nasdaq listing rule 5635(c)(4)

San diego--(business wire)--acadia pharmaceuticals inc. (nasdaq: acad) today announced that on november 8, 2024, the compensation committee of acadia's board of directors (the “committee”) granted inducement awards consisting of non-qualified stock options to purchase 70,571 shares of common stock and 40,731 restricted stock units (“rsus”) to twenty-three new employees under acadia's 2024 inducement plan. the compensation committee approved the awards as an inducement material to the new employ.
ACAD Ratings Summary
ACAD Quant Ranking